BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1832546)

  • 1. Functional and phenotypic analysis of lymphocytes in head and neck cancer.
    Snyderman CH; Heo DS; Johnson JT; D'Amico F; Barnes L; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):899-905. PubMed ID: 1832546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
    Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
    Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
    Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
    Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
    Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
    J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
    Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
    Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic effector cells in head and neck cancer.
    Vitolo D; Letessier EM; Johnson JT; Whiteside TL
    J Natl Cancer Inst Monogr; 1992; (13):203-8. PubMed ID: 1356393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neck node immunoreactivity in head and neck carcinoma.
    Mandell-Brown M; Johnson JT; Rabin BS; Hamill E; Wagner RL
    Otolaryngol Head Neck Surg; 1986 Nov; 95(4):500-6. PubMed ID: 2952933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
    Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
    J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression of CD11a on CD8+ cells is suppressed in regional lymph nodes with cancer involvement in patients with gastrointestinal carcinoma.
    Shinkal H; Kitayama J; Kimura W; Muto T; Shibata Y
    Cancer; 1996 Oct; 78(8):1677-85. PubMed ID: 8859180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity.
    Bagnasco M; Venuti D; Paolieri F; Torre G; Ferrini S; Canonica GW
    J Clin Endocrinol Metab; 1989 Oct; 69(4):832-6. PubMed ID: 2789232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
    Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
    Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study of immunological status in gastric cancer patients--with special reference to T-cell subsets in the lymphocytes of regional lymph nodes].
    Ohwada S; Takeshita M; Miyamoto Y; Izumi M
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1560-6. PubMed ID: 2263239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers.
    Vetto JT; Lum S; Morris A; Sicotte M; Davis J; Lemon M; Weinberg A
    Am J Surg; 1997 Sep; 174(3):258-65. PubMed ID: 9324133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer.
    Rubbert A; Manger B; Lang N; Kalden JR; Platzer E
    Int J Cancer; 1991 Aug; 49(1):25-31. PubMed ID: 1908441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer.
    Snyderman CH; Heo DS; Chen K; Whiteside TL; Johnson JT
    Head Neck; 1989; 11(4):331-6. PubMed ID: 2502505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of lymphokine-activated lymphocytes. Lysis of human head and neck squamous cell carcinoma cell lines.
    Alessi DM; Hutcherson RW; Mickel RA
    Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):725-30. PubMed ID: 2785809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.